Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University Many biochemical processes have been described for the detection of antigens. These processes have high specificity, have high reproducibility, and are trustworthy. Several new biochemical processes are being developed with even better sensitivity. However, the downside of biochemical processes is that they are slow and require specialized […]
Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]
Prama Ghosh, Amity University Kolkata Researchers at the University of Bonn, Germany, have identified and developed novel antibody fragments against the SARS coronavirus-2. These antibody fragments are smaller than classic antibodies and hence are called nanobodies. These nanobodies are better at penetrating the tissues and also can be produced in large quantities. The nanobodies were also […]
Thota Kanishka Rao, Amity University Kolkata A pregnant Singaporean woman, infected by the coronavirus gave birth to a baby with antibodies against the virus, giving insight to the fact if the virus can be transformed from mother to child. The women’s doctors suspect that the mother, who got infected by the by the virus during […]
Ayooshi Mitra, Amity University Kolkata COVID-19 has presented various contradictions that may provide clues to control the pandemic, even before a COVID-19 vaccine is widely available. A study conducted recently by a group of researchers has shown that the measles-mumps-rubella (MMR) vaccine is theoretically capable of protecting against COVID-19. Mumps IgG titers or antibody levels […]
AISHILA KAR, AMITY UNIVERSITY KOLKATA Severe respiratory problem coronavirus 2 (SARS-CoV-2) has fastly spread within the human population. In spite of the fact, SARS-CoV-2 is a novel coronavirus, most humans had been early exposed to other antigenically different common seasonal human coronaviruses (hCoVs) earlier than the COVID-19 pandemic. Few scientists have suggested that people might […]
Prama Ghosh, Amity University Kolkata The utilization of antibodies to battle human illness goes back to the 1890s and it is in practice even today. The blood plasma of patients who have recovered from COVID-19 contains antibodies against the SARS-CoV-2 virus which is called plasma therapy and used as a treatment for people with coronavirus […]
Sayan Roy, Pondicherry University mRNA-1273 is a messenger RNA (mRNA) vaccine, designed to fight against Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). It is developed by a US-based pharmaceutical company- Moderna, in association with NIAID Vaccine Research Center. The mRNA-1273 vaccine encodes for the SARS-CoV-2 full-length spike glycoprotein trimer ‘S-2P’, but modified to incorporate two proline substitutions […]
Prama Ghosh, Amity University Kolkata A study carried out at Houston Methodist Hospital and UT Austin involving around 5000 COVID-19 patients found that genetic mutations are getting accumulated in the causative virus which is making it more contagious. Located in the spike protein, the mutation is called D614G according to the peer-reviewed journal Ambio. Random genetic […]
Prama Ghosh, Amity University Kolkata The current critical situation due to COVID–19 has resulted in excessive centralization of biomanufacturing capacities which is a matter of great concern. But on the brighter side, sharing of scientific data and information globally at an unprecedented speed has helped strengthen our ability in developing new solutions based on technology. […]
